Day Range1.420 - 1.470 | 52 Wk Range0.220 - 7.050 | Open / Close1.450 / - | Float / Outstanding12.069M / 12.233M |
Vol / Avg.95.554K / 361.629K | Mkt Cap17.983M | P/E- | 50d Avg. Price1.140 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float12.069M | EPS-3.220 |
Iterum Therapeutics Stock (NASDAQ: ITRM) stock price, news, charts, stock research, profile.
Day Range1.420 - 1.470 | 52 Wk Range0.220 - 7.050 | Open / Close1.450 / - | Float / Outstanding12.069M / 12.233M |
Vol / Avg.95.554K / 361.629K | Mkt Cap17.983M | P/E- | 50d Avg. Price1.140 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float12.069M | EPS-3.220 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-27 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.050 | -0.430 | 0.6200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Iterum Therapeutics (NASDAQ: ITRM) through any online brokerage.
Other companies in Iterum Therapeutics’s space includes: Cingulate (NASDAQ:CING), Graybug Vision (NASDAQ:GRAY), Onconova Therapeutics (NASDAQ:ONTX), Cocrystal Pharma (NASDAQ:COCP) and Akanda (NASDAQ:AKAN).
The latest price target for Iterum Therapeutics (NASDAQ: ITRM) was reported by Gabelli & Co. on Tuesday, July 27, 2021. The analyst firm set a price target for 0.00 expecting ITRM to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Iterum Therapeutics (NASDAQ: ITRM) is $1.47 last updated Today at February 2, 2023 at 6:39 PM UTC.
There are no upcoming dividends for Iterum Therapeutics.
Iterum Therapeutics’s Q4 earnings are confirmed for Monday, March 27, 2023.
There is no upcoming split for Iterum Therapeutics.
Iterum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Iterum Therapeutics Stock (NASDAQ: ITRM) stock price, news, charts, stock research, profile.
Day Range1.420 - 1.470 | 52 Wk Range0.220 - 7.050 | Open / Close1.450 / - | Float / Outstanding12.069M / 12.233M |
Vol / Avg.95.554K / 361.629K | Mkt Cap17.983M | P/E- | 50d Avg. Price1.140 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float12.069M | EPS-3.220 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-27 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.050 | -0.430 | 0.6200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Iterum Therapeutics (NASDAQ: ITRM) through any online brokerage.
Other companies in Iterum Therapeutics’s space includes: Cingulate (NASDAQ:CING), Graybug Vision (NASDAQ:GRAY), Onconova Therapeutics (NASDAQ:ONTX), Cocrystal Pharma (NASDAQ:COCP) and Akanda (NASDAQ:AKAN).
The latest price target for Iterum Therapeutics (NASDAQ: ITRM) was reported by Gabelli & Co. on Tuesday, July 27, 2021. The analyst firm set a price target for 0.00 expecting ITRM to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Iterum Therapeutics (NASDAQ: ITRM) is $1.47 last updated Today at February 2, 2023 at 6:39 PM UTC.
There are no upcoming dividends for Iterum Therapeutics.
Iterum Therapeutics’s Q4 earnings are confirmed for Monday, March 27, 2023.
There is no upcoming split for Iterum Therapeutics.
Iterum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Iterum Therapeutics Stock (NASDAQ: ITRM) stock price, news, charts, stock research, profile.
Day Range1.420 - 1.470 | 52 Wk Range0.220 - 7.050 | Open / Close1.450 / - | Float / Outstanding12.069M / 12.233M |
Vol / Avg.95.554K / 361.629K | Mkt Cap17.983M | P/E- | 50d Avg. Price1.140 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float12.069M | EPS-3.220 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-27 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.050 | -0.430 | 0.6200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Iterum Therapeutics (NASDAQ: ITRM) through any online brokerage.
Other companies in Iterum Therapeutics’s space includes: Cingulate (NASDAQ:CING), Graybug Vision (NASDAQ:GRAY), Onconova Therapeutics (NASDAQ:ONTX), Cocrystal Pharma (NASDAQ:COCP) and Akanda (NASDAQ:AKAN).
The latest price target for Iterum Therapeutics (NASDAQ: ITRM) was reported by Gabelli & Co. on Tuesday, July 27, 2021. The analyst firm set a price target for 0.00 expecting ITRM to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Iterum Therapeutics (NASDAQ: ITRM) is $1.47 last updated Today at February 2, 2023 at 6:39 PM UTC.
There are no upcoming dividends for Iterum Therapeutics.
Iterum Therapeutics’s Q4 earnings are confirmed for Monday, March 27, 2023.
There is no upcoming split for Iterum Therapeutics.
Iterum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Iterum Therapeutics Stock (NASDAQ: ITRM) stock price, news, charts, stock research, profile.
Day Range1.420 - 1.470 | 52 Wk Range0.220 - 7.050 | Open / Close1.450 / - | Float / Outstanding12.069M / 12.233M |
Vol / Avg.95.554K / 361.629K | Mkt Cap17.983M | P/E- | 50d Avg. Price1.140 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float12.069M | EPS-3.220 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-27 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.050 | -0.430 | 0.6200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Iterum Therapeutics (NASDAQ: ITRM) through any online brokerage.
Other companies in Iterum Therapeutics’s space includes: Cingulate (NASDAQ:CING), Graybug Vision (NASDAQ:GRAY), Onconova Therapeutics (NASDAQ:ONTX), Cocrystal Pharma (NASDAQ:COCP) and Akanda (NASDAQ:AKAN).
The latest price target for Iterum Therapeutics (NASDAQ: ITRM) was reported by Gabelli & Co. on Tuesday, July 27, 2021. The analyst firm set a price target for 0.00 expecting ITRM to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Iterum Therapeutics (NASDAQ: ITRM) is $1.47 last updated Today at February 2, 2023 at 6:39 PM UTC.
There are no upcoming dividends for Iterum Therapeutics.
Iterum Therapeutics’s Q4 earnings are confirmed for Monday, March 27, 2023.
There is no upcoming split for Iterum Therapeutics.
Iterum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Iterum Therapeutics Stock (NASDAQ: ITRM) stock price, news, charts, stock research, profile.
Day Range1.420 - 1.470 | 52 Wk Range0.220 - 7.050 | Open / Close1.450 / - | Float / Outstanding12.069M / 12.233M |
Vol / Avg.95.554K / 361.629K | Mkt Cap17.983M | P/E- | 50d Avg. Price1.140 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float12.069M | EPS-3.220 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-27 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.050 | -0.430 | 0.6200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Iterum Therapeutics (NASDAQ: ITRM) through any online brokerage.
Other companies in Iterum Therapeutics’s space includes: Cingulate (NASDAQ:CING), Graybug Vision (NASDAQ:GRAY), Onconova Therapeutics (NASDAQ:ONTX), Cocrystal Pharma (NASDAQ:COCP) and Akanda (NASDAQ:AKAN).
The latest price target for Iterum Therapeutics (NASDAQ: ITRM) was reported by Gabelli & Co. on Tuesday, July 27, 2021. The analyst firm set a price target for 0.00 expecting ITRM to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Iterum Therapeutics (NASDAQ: ITRM) is $1.47 last updated Today at February 2, 2023 at 6:39 PM UTC.
There are no upcoming dividends for Iterum Therapeutics.
Iterum Therapeutics’s Q4 earnings are confirmed for Monday, March 27, 2023.
There is no upcoming split for Iterum Therapeutics.
Iterum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Iterum Therapeutics Stock (NASDAQ: ITRM) stock price, news, charts, stock research, profile.
Day Range1.420 - 1.470 | 52 Wk Range0.220 - 7.050 | Open / Close1.450 / - | Float / Outstanding12.069M / 12.233M |
Vol / Avg.95.554K / 361.629K | Mkt Cap17.983M | P/E- | 50d Avg. Price1.140 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float12.069M | EPS-3.220 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-27 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.050 | -0.430 | 0.6200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Iterum Therapeutics (NASDAQ: ITRM) through any online brokerage.
Other companies in Iterum Therapeutics’s space includes: Cingulate (NASDAQ:CING), Graybug Vision (NASDAQ:GRAY), Onconova Therapeutics (NASDAQ:ONTX), Cocrystal Pharma (NASDAQ:COCP) and Akanda (NASDAQ:AKAN).
The latest price target for Iterum Therapeutics (NASDAQ: ITRM) was reported by Gabelli & Co. on Tuesday, July 27, 2021. The analyst firm set a price target for 0.00 expecting ITRM to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Iterum Therapeutics (NASDAQ: ITRM) is $1.47 last updated Today at February 2, 2023 at 6:39 PM UTC.
There are no upcoming dividends for Iterum Therapeutics.
Iterum Therapeutics’s Q4 earnings are confirmed for Monday, March 27, 2023.
There is no upcoming split for Iterum Therapeutics.
Iterum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Iterum Therapeutics Stock (NASDAQ: ITRM) stock price, news, charts, stock research, profile.
Day Range1.420 - 1.470 | 52 Wk Range0.220 - 7.050 | Open / Close1.450 / - | Float / Outstanding12.069M / 12.233M |
Vol / Avg.95.554K / 361.629K | Mkt Cap17.983M | P/E- | 50d Avg. Price1.140 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float12.069M | EPS-3.220 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-27 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.050 | -0.430 | 0.6200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Iterum Therapeutics (NASDAQ: ITRM) through any online brokerage.
Other companies in Iterum Therapeutics’s space includes: Cingulate (NASDAQ:CING), Graybug Vision (NASDAQ:GRAY), Onconova Therapeutics (NASDAQ:ONTX), Cocrystal Pharma (NASDAQ:COCP) and Akanda (NASDAQ:AKAN).
The latest price target for Iterum Therapeutics (NASDAQ: ITRM) was reported by Gabelli & Co. on Tuesday, July 27, 2021. The analyst firm set a price target for 0.00 expecting ITRM to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Iterum Therapeutics (NASDAQ: ITRM) is $1.47 last updated Today at February 2, 2023 at 6:39 PM UTC.
There are no upcoming dividends for Iterum Therapeutics.
Iterum Therapeutics’s Q4 earnings are confirmed for Monday, March 27, 2023.
There is no upcoming split for Iterum Therapeutics.
Iterum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Iterum Therapeutics Stock (NASDAQ: ITRM) stock price, news, charts, stock research, profile.
Day Range1.420 - 1.470 | 52 Wk Range0.220 - 7.050 | Open / Close1.450 / - | Float / Outstanding12.069M / 12.233M |
Vol / Avg.95.554K / 361.629K | Mkt Cap17.983M | P/E- | 50d Avg. Price1.140 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float12.069M | EPS-3.220 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-27 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.050 | -0.430 | 0.6200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Iterum Therapeutics (NASDAQ: ITRM) through any online brokerage.
Other companies in Iterum Therapeutics’s space includes: Cingulate (NASDAQ:CING), Graybug Vision (NASDAQ:GRAY), Onconova Therapeutics (NASDAQ:ONTX), Cocrystal Pharma (NASDAQ:COCP) and Akanda (NASDAQ:AKAN).
The latest price target for Iterum Therapeutics (NASDAQ: ITRM) was reported by Gabelli & Co. on Tuesday, July 27, 2021. The analyst firm set a price target for 0.00 expecting ITRM to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Iterum Therapeutics (NASDAQ: ITRM) is $1.47 last updated Today at February 2, 2023 at 6:39 PM UTC.
There are no upcoming dividends for Iterum Therapeutics.
Iterum Therapeutics’s Q4 earnings are confirmed for Monday, March 27, 2023.
There is no upcoming split for Iterum Therapeutics.
Iterum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Iterum Therapeutics Stock (NASDAQ: ITRM) stock price, news, charts, stock research, profile.
Day Range1.420 - 1.470 | 52 Wk Range0.220 - 7.050 | Open / Close1.450 / - | Float / Outstanding12.069M / 12.233M |
Vol / Avg.95.554K / 361.629K | Mkt Cap17.983M | P/E- | 50d Avg. Price1.140 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float12.069M | EPS-3.220 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-27 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.050 | -0.430 | 0.6200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Iterum Therapeutics (NASDAQ: ITRM) through any online brokerage.
Other companies in Iterum Therapeutics’s space includes: Cingulate (NASDAQ:CING), Graybug Vision (NASDAQ:GRAY), Onconova Therapeutics (NASDAQ:ONTX), Cocrystal Pharma (NASDAQ:COCP) and Akanda (NASDAQ:AKAN).
The latest price target for Iterum Therapeutics (NASDAQ: ITRM) was reported by Gabelli & Co. on Tuesday, July 27, 2021. The analyst firm set a price target for 0.00 expecting ITRM to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Iterum Therapeutics (NASDAQ: ITRM) is $1.47 last updated Today at February 2, 2023 at 6:39 PM UTC.
There are no upcoming dividends for Iterum Therapeutics.
Iterum Therapeutics’s Q4 earnings are confirmed for Monday, March 27, 2023.
There is no upcoming split for Iterum Therapeutics.
Iterum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.